Profiling of circulating serum exosomal microRNAs in elderly patients with infectious stress hyperglycaemia

Quick Facts

• Publication title: Profiling of circulating serum exosomal microRNAs in elderly patients with infectious stress hyperglycaemia
• Journal: Clin Transl Discov
• Year: 2023
• DOI: 10.1002/ctd2.205

Research overview

Aim and methodSystematic screening of specific biomarkers of serum exosome‐derived microRNAs (sE‐miRNAs) from ISH patient has not yet been reported. ConclusionThis study depicted the circulating exosomal miRNAs change in ISH patient, which could be used as a promising biomarker to detect ISH at an early stage and predict patients clinical outcome.

Echo Biotech Role

Echo Biotech contributed EV isolation and purification, EV characterization, miRNA profiling/sequencing and bioinformatic analysis, qPCR validation; the study also used or cited Exosupur®.

Related platforms: Exoomics®, Research Reagents & Tools

Related services and capabilities: Biofluid EV Isolation & Purification, EV Basic Characterization (TEM/NTA/WB), EV miRNA Profiling / Sequencing, qPCR Validation, Research Reagent / Product Supply

Related products or reagents: Exosupur® EV Isolation/Purification Kit

References

Original publication: Profiling of circulating serum exosomal microRNAs in elderly patients with infectious stress hyperglycaemia Clin Transl Discov. 2023. DOI: 10.1002/ctd2.205.